| Association between mRNA vaccination and COVID-19 hospitalization and disease severity MW Tenforde, WH Self, K Adams, M Gaglani, AA Ginde, T McNeal, ... Jama 326 (20), 2043-2054, 2021 | 607 | 2021 |
| Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study AS Lauring, MW Tenforde, JD Chappell, M Gaglani, AA Ginde, T McNeal, ... bmj 376, 2022 | 541 | 2022 |
| Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising … WH Self MMWR. Morbidity and mortality weekly report 70, 2021 | 472 | 2021 |
| Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged≥ 65 years—United States, January–March 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 329 | 2021 |
| Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 251 | 2021 |
| Effectiveness of SARS-CoV-2 mRNA vaccines for preventing Covid-19 hospitalizations in the United States MW Tenforde, MM Patel, AA Ginde, DJ Douin, HK Talbot, JD Casey, ... MedRxiv, 2021 | 158 | 2021 |
| Effectiveness of mRNA vaccination in preventing COVID-19–associated invasive mechanical ventilation and death—United States, March 2021–January 2022 MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 154 | 2022 |
| Effectiveness of a third dose of Pfizer-BioNTech and Moderna vaccines in preventing COVID-19 hospitalization among immunocompetent and immunocompromised adults—United States … MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 92 | 2022 |
| Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States Clinical Infectious Diseases, 2021 | 84* | 2021 |
| Effectiveness of monovalent mRNA vaccines against COVID-19–associated hospitalization among immunocompetent adults during BA. 1/BA. 2 and BA. 4/BA. 5 predominant periods of … D Surie MMWR. Morbidity and mortality weekly report 71, 2022 | 58 | 2022 |
| Clinical severity and mRNA vaccine effectiveness for omicron, delta, and alpha SARS-CoV-2 variants in the United States: a prospective observational study AS Lauring, MW Tenforde, JD Chappell, M Gaglani, AA Ginde, T McNeal, ... MedRxiv, 2022 | 54 | 2022 |
| Influenza and Other Viruses in the Acutely Ill (IVY) Network. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV … AS Lauring, MW Tenforde, JD Chappell, M Gaglani, AA Ginde, T McNeal, ... BMJ 376, e069761, 2022 | 50 | 2022 |
| Influenza and Other Viruses in the Acutely Ill (IVY) Network MW Tenforde, WH Self, K Adams, M Gaglani, AA Ginde, T McNeal, ... Association between mRNA vaccination and COVID-19 hospitalization and …, 2021 | 47 | 2021 |
| IVY network; HAIVEN Investigators. Effectiveness of Pfizer-BioNTech and moderna vaccines against COVID-19 among hospitalized adults aged≥ 65 years—United States, January … MW Tenforde, SM Olson, WH Self, HK Talbot, CJ Lindsell, JS Steingrub, ... MMWR Morb Mortal Wkly Rep 70 (18), 674-679, 2021 | 46 | 2021 |
| mRNA vaccine effectiveness against coronavirus disease 2019 hospitalization among solid organ transplant recipients JH Kwon, MW Tenforde, M Gaglani, HK Talbot, AA Ginde, T McNeal, ... The Journal of infectious diseases 226 (5), 797-807, 2022 | 28 | 2022 |
| Influenza and Other Viruses in the Acutely Ill (IVY) Network. Effectiveness of SARS-CoV-2 mRNA vaccines for preventing COVID-19 hospitalizations in the United States MW Tenforde, MM Patel, AA Ginde, DJ Douin, HK Talbot, JD Casey, ... Clin Infect Dis, 2021 | 26 | 2021 |
| Effectiveness of mRNA vaccines against COVID-19 hospitalization by age and chronic medical conditions burden among immunocompetent US adults, March-August 2021 NM Lewis, EA Naioti, WH Self, AA Ginde, DJ Douin, H Keipp Talbot, ... The Journal of infectious diseases 225 (10), 1694-1700, 2022 | 19 | 2022 |
| Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States MW Tenforde, WH Self, Y Zhu, EA Naioti, M Gaglani, AA Ginde, K Jensen, ... Clinical infectious diseases 76 (3), ciac381, 2023 | 7 | 2023 |
| Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States C Turbyfill, K Adams, MW Tenforde, NL Murray, M Gaglani, AA Ginde, ... Vaccine 40 (48), 6979-6986, 2022 | 5 | 2022 |
| Effectiveness of the Ad26. COV2. S (Johnson & Johnson) coronavirus disease 2019 (COVID-19) vaccine for preventing COVID-19 hospitalizations and progression to high disease … NM Lewis, WH Self, M Gaglani, AA Ginde, DJ Douin, H Keipp Talbot, ... Clinical Infectious Diseases 75 (Supplement_2), S159-S166, 2022 | 5 | 2022 |
